Lonnel Coats - Feb 28, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Lonnel Coats
Stock symbol
LXRX
Transactions as of
Feb 28, 2023
Transactions value $
-$110,607
Form type
4
Date filed
3/1/2023, 03:46 PM
Previous filing
Feb 13, 2023
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +84.6K +14.44% 671K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +33.3K +4.97% 704K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Options Exercise +91.4K +12.98% 795K Feb 28, 2023 Direct F1
transaction LXRX Common Stock Tax liability -$111K -51K -6.41% $2.17 744K Feb 28, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -84.6K -100% 0 Feb 28, 2023 Common Stock 84.6K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -33.3K -50% 33.3K Feb 28, 2023 Common Stock 33.3K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -91.4K -33.33% 183K Feb 28, 2023 Common Stock 91.4K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.